BUZZ-Amneal Pharma gains as co poised to join S&P SmallCap index

Reuters01-28
BUZZ-Amneal Pharma gains as co poised to join S&P SmallCap index

** Amneal Pharmaceuticals AMRX.O shares up 3.4% premarket to $14.30 as it's set to join S&P SmallCap 600 index .SPCY this week

** AMRX, maker of generic and specialty prescription drugs, to replace TTM Technologies TTMI.O in SPCY before the bell on Fri, Jan 30, S&P Dow Jones Indices said late Tues

** Printed circuit board maker TTMI migrating to S&P MidCap 400 .IDX to replace Civitas Resources CIVI.N, which is being acquired by SM Energy SM.N

** Stephens analyst Melissa Roberts points out in a note that she expects passive funds will need to buy ~22.9 mln AMRX shares, equating to 13 days of implied buying demand

** Bridgewater, New Jersey-based AMRX has ~314.4 mln shares outstanding for roughly $4 bln market cap

** Through Tues close, shares up about 60% over the past year

** All 5 analysts rate the stock "buy"; median PT $15, per LSEG data

(Lance Tupper is a Reuters market analyst. The views expressed are his own)

((lance.tupper@tr.com 1-646-279-6380))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment